News
January 30, 2017
November 12, 2024
FRONTEO, Inc. (Head Office: Minato-ku, Tokyo; President and CEO: Masahiro Morimoto; hereafter "FRONTEO") is pleased to announce that an agreement has been reached to provide Daiichi Sankyo Co., Ltd. (Head Office: Chuo-ku, Tokyo; President and COO: Hiroyuki Okuzawa; hereafter "Daiichi Sankyo") with analysis services using Drug Discovery AI Factory (hereafter "DDAIF")* to analyze text information from toxicity study databases and reports.
January 9, 2025
Accelerate indication identification and early licensing with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature information.
January 8, 2019
February 6, 2024
Enhanced function of the Drug Discovery AI Factory, analyze cutting-edge academic articles to propose highly novel target molecules and hypotheses
September 14, 2023
NEW YORK, September 14, 2023 – FRONTEO (TSE: 2158) has added a new function to its proprietary AI review tool "KIBIT Automator," which enables investigation of data from various chat tools, to view emojis in Slack, Microsoft Teams, SMS, and other chat applications. FRONTEO has also added the ability to delete duplicate conversations across chats. These new functions will be implemented simultaneously to FRONTEO’s on-premise forensic tool "KIBIT XAMINER”.
April 15, 2020
January 16, 2023
NEW YORK, January 16, 2023 – FRONTEO (TSE: 2158) has announced today that its proprietary AI engine "KIBIT" has successfully improved Japanese language processing in natural language processing.
March 14, 2019
November 2, 2021
KIBIT Automator, an AI-based e-discovery and digital forensics platform, runs on Microsoft Azure, the world's most secure environment.
November 10, 2022
AI Review Tool "KIBIT Automator"
Improved Landscaping and Precision Algorithms
AI Supports Strategic Efforts During Early Review Stages
January 28, 2025
Accelerate First in Class R&D with FRONTEO’s unique technologies that systematically discover unreported relationships between diseases and molecules from existing literature information.
January 12, 2024
FRONTEO is a proud sponsor of Legalweek 2024 at the New York Hilton Midtown – January 29th – February 1st. Come join your peers in the legal profession at this annual gathering.
February 29, 2024
FRONTEO, Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Masahiro Morimoto) is hosting a free seminar “Recent Developments in AI and Competition Law – a Global Perspective” in collaboration with White & Case LLP on March 19th.
May 13, 2024
FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO"), Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi"), and Suzuken Co., Ltd. (Head Office: Nagoya, Japan; President and CEO: Shigeru Asano; hereafter "Suzuken") are pleased to announce that we will collaborate with the aim of implementing the conversational dementia diagnosis support AI program in society.
April 15, 2022
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
January 30, 2024
We have enhanced our existing forensic services with new cutting-edge digital forensics software package, and we are working on adding more certified forensic experts to our staff.